Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 2
2017 19
2018 12
2019 7
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Cefiderocol: a novel siderophore cephalosporin.
Choi JJ, McCarthy MW. Choi JJ, et al. Among authors: mccarthy mw. Expert Opin Investig Drugs. 2018 Feb;27(2):193-197. doi: 10.1080/13543784.2018.1426745. Epub 2018 Jan 24. Expert Opin Investig Drugs. 2018. PMID: 29318906 Review.
The Care of the Ultra-Orthodox Jewish Patient.
Gabbay E, McCarthy MW, Fins JJ. Gabbay E, et al. Among authors: mccarthy mw. J Relig Health. 2017 Apr;56(2):545-560. doi: 10.1007/s10943-017-0356-6. J Relig Health. 2017. PMID: 28102466
Cefiderocol to treat complicated urinary tract infection.
McCarthy MW. McCarthy MW. Drugs Today (Barc). 2020 Mar;56(3):177-184. doi: 10.1358/dot.2020.56.3.3118466. Drugs Today (Barc). 2020. PMID: 32282864 Review.
On November 14, 2019, the U.S. Food and Drug Administration (FDA) approved cefiderocol, a siderophore-cephalosporin conjugate antibiotic, for the treatment of adults with complicated urinary tract infections (cUTIs), including kidney infections caused by susceptible Gram-n …
On November 14, 2019, the U.S. Food and Drug Administration (FDA) approved cefiderocol, a siderophore-cephalosporin conjugate antibio …
Teixobactin: a novel anti-infective agent.
McCarthy MW. McCarthy MW. Expert Rev Anti Infect Ther. 2019 Jan;17(1):1-3. doi: 10.1080/14787210.2019.1550357. Epub 2018 Nov 20. Expert Rev Anti Infect Ther. 2019. PMID: 30449226 No abstract available.
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page